Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WV › Pt Pleasant › NPI 1598975120
Hospital

Pleasant Valley Hospital, INC.

Pleasant Valley Hospital, INC. was paid $6.61M by Medicaid between Jan 2018 and Dec 2024, across 215 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.

33Billing provider infoPLEASANT VALLEY HOSPITAL, INC.
PT PLEASANT, WV 25550
33aNPI1598975120assigned 05/23/2007
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$6.61M
24GClaims326,767
24DCodes billed215
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Medicare Defined Swing Bed Hospital Unit providers in West Virginia

Rank by total paid#3 of 5
Median peer was paid$6.61M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201868,782$2.13M
201939,719$616K
202060,061$1.36M
202151,211$890K
202235,149$539K
202343,295$632K
2024incomplete28,550$438K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 12,444 11,485 $942K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.7% 3,075 2,680 $641K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.2% 3,036 2,706 $279K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.7% 28,457 22,290 $244K
80053 Comprehensive metabolic panel 3.6% 18,170 15,538 $235K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.4% 4,985 4,618 $225K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.9% 7,029 1,923 $192K
36415 Collection of venous blood by venipuncture 2.9% 34,278 24,303 $191K
80061 Lipid panel 1.7% 8,417 7,908 $113K
80048 Basic metabolic panel (calcium, ionized) 1.6% 11,419 8,533 $108K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1.6% 3,995 3,591 $107K
84443 Thyroid stimulating hormone (TSH) 1.6% 7,415 6,836 $104K
203 more codes
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.6% 2,803 $103K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.5% 4,490 $99K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.4% 1,709 $94K
96361 Intravenous infusion, hydration; each additional hour 1.4% 2,495 $93K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.3% 913 $86K
70450 Computed tomography, head or brain; without contrast material 1.3% 1,720 $84K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.1% 643 $73K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.1% 862 $71K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.0% 3,470 $69K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 5,214 $65K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,869 $64K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,536 $64K
71046 Radiologic examination, chest; 2 views <1% 3,158 $63K
84484 <1% 3,612 $62K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,771 $59K
83036 Hemoglobin; glycosylated (A1C) <1% 6,082 $57K
83735 <1% 5,541 $57K
82550 <1% 2,087 $54K
71045 Radiologic examination, chest; single view <1% 4,364 $52K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 2,501 $52K
82553 <1% 1,596 $51K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,178 $50K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 2,604 $49K
81001 <1% 5,693 $48K
96375 Therapeutic injection; each additional sequential IV push <1% 2,685 $48K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 5,684 $48K
83874 <1% 1,574 $47K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 243 $46K
80076 <1% 2,687 $41K
83690 <1% 2,766 $40K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 438 $38K
84439 <1% 3,257 $37K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,330 $37K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,033 $37K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 672 $36K
82150 <1% 1,516 $34K
80348 <1% 3,027 $31K
85610 <1% 3,367 $30K
81003 <1% 2,685 $30K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,932 $29K
80074 <1% 511 $28K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 94 $27K
81025 <1% 994 $27K
77067 Screening mammography, bilateral, including computer-aided detection <1% 398 $24K
83605 <1% 2,178 $23K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 110 $23K
83880 <1% 1,066 $23K
85730 <1% 1,483 $22K
82607 <1% 1,731 $22K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 645 $21K
93017 <1% 114 $19K
94761 <1% 410 $19K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 985 $18K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 481 $18K
87186 <1% 1,729 $17K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 678 $17K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 459 $17K
J2785 Injection, regadenoson, 0.1 mg <1% 79 $15K
85027 <1% 1,252 $15K
97162 <1% 435 $15K
G0378 Hospital observation service, per hour <1% 352 $15K
87807 <1% 1,083 $14K
73630 <1% 399 $14K
85007 <1% 1,216 $14K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 222 $14K
83992 <1% 876 $14K
80346 <1% 907 $13K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 176 $13K
84145 <1% 1,165 $12K
82248 <1% 390 $12K
87486 <1% 161 $11K
87581 <1% 161 $11K
80305 <1% 575 $11K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 326 $10K
74022 <1% 411 $10K
73610 <1% 244 $10K
87040 <1% 826 $10K
80361 <1% 896 $10K
87088 <1% 649 $9K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 55 $9K
96376 <1% 406 $9K
87522 Neg quan hep c or qual rna <1% 209 $8K
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled <1% 8,407 $8K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 14 $8K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 579 $8K
83540 <1% 1,275 $8K
73562 <1% 249 $8K
80326 <1% 894 $8K
84481 <1% 633 $8K
72110 <1% 214 $8K
86886 <1% 364 $7K
80360 <1% 899 $7K
82947 <1% 945 $7K
87205 <1% 317 $6K
82948 <1% 186 $6K
80373 <1% 894 $6K
87070 <1% 293 $6K
80354 <1% 877 $6K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 293 $6K
82565 <1% 693 $6K
73130 <1% 99 $6K
83550 <1% 864 $6K
86780 <1% 423 $5K
87517 <1% 148 $5K
94664 <1% 216 $5K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 338 $5K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 84 $5K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 93 $5K
A9270 Non-covered item or service <1% 2,640 $5K
87081 <1% 555 $5K
73030 <1% 149 $5K
86592 <1% 126 $4K
86480 <1% 77 $4K
85651 <1% 530 $4K
76536 <1% 65 $4K
84550 <1% 98 $4K
82043 <1% 379 $4K
80355 <1% 907 $4K
80358 <1% 895 $4K
80371 <1% 894 $4K
80367 <1% 894 $4K
80372 <1% 894 $4K
80370 <1% 894 $4K
80365 <1% 894 $4K
80368 <1% 894 $4K
80364 <1% 877 $4K
80359 <1% 877 $4K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 273 $4K
82746 <1% 331 $4K
97161 <1% 116 $4K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 2,116 $4K
82728 <1% 445 $4K
87077 <1% 131 $4K
84460 <1% 398 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 29 $3K
99213 Doctor's office visit, returning patient (routine) <1% 105 $3K
84132 <1% 424 $3K
86803 <1% 82 $3K
88142 <1% 53 $3K
73110 <1% 31 $3K
86140 <1% 533 $3K
80353 <1% 520 $2K
80366 <1% 513 $2K
80321 <1% 141 $2K
99214 Doctor's office visit, returning patient (more involved) <1% 122 $2K
86704 <1% 192 $2K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 18 $2K
86705 <1% 17 $1K
77063 Screening digital breast tomosynthesis, bilateral <1% 109 $1K
86706 <1% 156 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 55 $1K
80349 <1% 121 $1K
83525 <1% 98 $1K
87340 <1% 137 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 15 $1K
84295 <1% 280 $1K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 56 $1K
84520 <1% 176 $1K
97165 <1% 26 $1K
85379 <1% 100 $907.49
97116 <1% 53 $889.34
94760 <1% 77 $860.06
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 24 $842.75
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 54 $759.62
86708 <1% 62 $673.81
82172 <1% 42 $632.99
76830 Ultrasound, transvaginal <1% 13 $627.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 990 $590.68
80164 <1% 13 $562.76
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 27 $499.06
80050 General health panel <1% 14 $459.22
83883 <1% 42 $447.85
83010 <1% 42 $414.24
85018 <1% 18 $396.87
85014 <1% 18 $396.87
87350 <1% 20 $332.16
93880 <1% 13 $301.94
J3490 Unclassified drugs <1% 931 $274.39
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 20 $273.79
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals <1% 20 $273.79
82977 <1% 42 $237.08
72100 <1% 20 $227.59
84153 <1% 14 $224.92
97597 <1% 22 $213.30
86901 <1% 26 $210.18
86900 <1% 26 $210.18
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 15 $177.36
86141 <1% 13 $137.53
71101 <1% 13 $127.38
90686 <1% 58 $121.44
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 457 $117.22
86850 <1% 13 $112.82
83615 <1% 18 $59.29
84450 <1% 13 $53.97
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 704 $47.61
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 257 $39.10
J2704 Injection, propofol, 10 mg <1% 84 $28.69
G0008 Administration of influenza virus vaccine <1% 77 $21.11
84100 <1% 14 $15.89
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 193 $10.51
J1170 Injection, hydromorphone, up to 4 mg <1% 54 $6.51
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 1,313 $2.77
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 15 $0.76

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGROVES, TASHA (CREDENTIALING)
Same official

Other billing entities under GROVES, TASHA

Full network →
ProviderLocationPaid
Pleasant Valley Hospital, INC.Point Pleasant, WV$6.64M
Point Pleasant Physician Billing ServicesPt Pleasant, WV$2.18M
Pleasant Valley Hospital INCMason, WV$1.01M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.